EP1786408A4 - Verwendung eines selektiven östrogenrezeptormodulators zur herstellung eines pharmazeutischen präparates zur verwendung in einem verfahren für die behandlung oder vorbeugung von androgenmangel - Google Patents
Verwendung eines selektiven östrogenrezeptormodulators zur herstellung eines pharmazeutischen präparates zur verwendung in einem verfahren für die behandlung oder vorbeugung von androgenmangelInfo
- Publication number
- EP1786408A4 EP1786408A4 EP05771627A EP05771627A EP1786408A4 EP 1786408 A4 EP1786408 A4 EP 1786408A4 EP 05771627 A EP05771627 A EP 05771627A EP 05771627 A EP05771627 A EP 05771627A EP 1786408 A4 EP1786408 A4 EP 1786408A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- prevention
- manufacture
- treatment
- pharmaceutical preparation
- estrogen receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60690704P | 2004-09-03 | 2004-09-03 | |
FI20041216A FI20041216A0 (fi) | 2004-09-21 | 2004-09-21 | Menetelmä androgeenivajeen hoitoon tai estoon |
PCT/FI2005/000333 WO2006024689A1 (en) | 2004-09-03 | 2005-07-20 | Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1786408A1 EP1786408A1 (de) | 2007-05-23 |
EP1786408A4 true EP1786408A4 (de) | 2010-07-28 |
Family
ID=35999733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05771627A Withdrawn EP1786408A4 (de) | 2004-09-03 | 2005-07-20 | Verwendung eines selektiven östrogenrezeptormodulators zur herstellung eines pharmazeutischen präparates zur verwendung in einem verfahren für die behandlung oder vorbeugung von androgenmangel |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1786408A4 (de) |
JP (1) | JP2008511615A (de) |
KR (1) | KR20070059110A (de) |
AU (1) | AU2005279178A1 (de) |
BR (1) | BRPI0514701A (de) |
CA (1) | CA2578852A1 (de) |
MX (1) | MX2007002606A (de) |
NO (1) | NO20071160L (de) |
RU (1) | RU2007112114A (de) |
WO (1) | WO2006024689A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009008660A (es) | 2007-02-14 | 2009-10-13 | Hormos Medical Ltd | Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos. |
WO2008157335A2 (en) * | 2007-06-13 | 2008-12-24 | Quatrx Pharmaceuticals Company | Methods for the treatment of erectile dysfunction using fispemifene |
MX2012014431A (es) | 2010-06-10 | 2013-02-26 | Aragon Pharmaceuticals Inc | Modulares del receptor de estrogenos y usos de los mismos. |
BR112014014124A2 (pt) | 2011-12-14 | 2017-08-22 | Seragon Pharmaceutical Inc | Moduladores do receptor de estrogênio fluorados e usos dos mesmos |
US9744177B2 (en) * | 2014-03-10 | 2017-08-29 | Endorecherche, Inc. | Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM |
ES2717546T3 (es) | 2014-12-29 | 2019-06-21 | Olon Spa | Proceso para la preparación de ospemifeno y fispemifeno |
WO2023175010A1 (fr) * | 2022-03-15 | 2023-09-21 | Centre D'etude Des Cellules Souches (Cecs) | Utilisation du bazedoxifene pour augmenter la survie musculaire |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036360A1 (en) * | 1999-11-16 | 2001-05-25 | Hormos Medical Corporation | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL120262A (en) * | 1996-02-28 | 2001-01-28 | Pfizer | Droloxifene and derivatives thereof for use in increasing serum testosterone levels |
US6632447B1 (en) * | 1998-05-07 | 2003-10-14 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
CO5271697A1 (es) * | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona |
US7067557B2 (en) * | 2000-05-26 | 2006-06-27 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
EP1289519B1 (de) * | 2000-05-26 | 2019-02-13 | Harry Fisch | Verfahren zur behandlung von androgendefizienz im männer mit clomiphen |
DE60226494D1 (de) * | 2001-11-29 | 2008-06-19 | Gtx Inc | Vorbeugung und behandlung von durch androgenmangel induzierter osteoporose |
-
2005
- 2005-07-20 MX MX2007002606A patent/MX2007002606A/es unknown
- 2005-07-20 AU AU2005279178A patent/AU2005279178A1/en not_active Abandoned
- 2005-07-20 EP EP05771627A patent/EP1786408A4/de not_active Withdrawn
- 2005-07-20 JP JP2007529372A patent/JP2008511615A/ja not_active Abandoned
- 2005-07-20 KR KR1020077006922A patent/KR20070059110A/ko not_active Application Discontinuation
- 2005-07-20 RU RU2007112114/15A patent/RU2007112114A/ru not_active Application Discontinuation
- 2005-07-20 BR BRPI0514701-8A patent/BRPI0514701A/pt not_active IP Right Cessation
- 2005-07-20 WO PCT/FI2005/000333 patent/WO2006024689A1/en active Application Filing
- 2005-07-20 CA CA002578852A patent/CA2578852A1/en not_active Abandoned
-
2007
- 2007-03-01 NO NO20071160A patent/NO20071160L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036360A1 (en) * | 1999-11-16 | 2001-05-25 | Hormos Medical Corporation | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
Non-Patent Citations (3)
Title |
---|
DUSCHEK ERIK J J ET AL: "Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men", EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol. 150, no. 4, April 2004 (2004-04-01), pages 539 - 546, XP002586475, ISSN: 0804-4643 * |
See also references of WO2006024689A1 * |
STEINER MITCHELL S ET AL: "Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.", CLINICAL PROSTATE CANCER JUN 2003 LNKD- PUBMED:15046680, vol. 2, no. 1, June 2003 (2003-06-01), pages 24 - 31, XP009134590, ISSN: 1540-0352 * |
Also Published As
Publication number | Publication date |
---|---|
JP2008511615A (ja) | 2008-04-17 |
WO2006024689A1 (en) | 2006-03-09 |
NO20071160L (no) | 2007-05-25 |
BRPI0514701A (pt) | 2008-06-24 |
RU2007112114A (ru) | 2008-10-10 |
MX2007002606A (es) | 2007-05-15 |
EP1786408A1 (de) | 2007-05-23 |
KR20070059110A (ko) | 2007-06-11 |
CA2578852A1 (en) | 2006-03-09 |
AU2005279178A1 (en) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1829518A4 (de) | Medikamentenmixer zur verabreichung von arzneimitteln | |
EP1781183A4 (de) | Vorrichtungen und verfahren für die pylorusverankerung | |
EP1962722A4 (de) | Verfahren und systeme zur behandlung von aneurysmen unter verwendung von füllstrukturen | |
EP1733310A4 (de) | System und verfahren zur herstellung von orthesen | |
ZA200701156B (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
EP1740481A4 (de) | Eine optische bestätigung des verschliessens bereitstellende verschlussvorrichtung | |
EP1972251A4 (de) | Kapselbehälter und verabreichungsverfahren damit | |
IL209402A (en) | A process for making opioid receptor regulators and opioid receptor regulators made by him | |
EP1786408A4 (de) | Verwendung eines selektiven östrogenrezeptormodulators zur herstellung eines pharmazeutischen präparates zur verwendung in einem verfahren für die behandlung oder vorbeugung von androgenmangel | |
PL1786744T3 (pl) | Sposób opóźniania wiązania gipsu i preparatów gipsowych | |
IL182287A0 (en) | A method of contraception utilizing hormonal treatment | |
ZA200700483B (en) | Process for the preparation 2-substituted-derivatives of estrone and estradiol | |
ZA200705086B (en) | Catalytic materials and method for the preparation thereof | |
PL2063881T3 (pl) | Kompozycja i sposób na skuteczne i bezpieczne podawanie halopirogronianu w leczeniu nowotworów | |
EP2138168A4 (de) | Mittel zur oralen verabreichung und herstellungsverfahren dafür | |
EP1753405A4 (de) | Pharmazeutische formulierung mit kontrollierter freisetzung | |
EP1809266A4 (de) | Verbindungen und verfahren gegen krebs | |
ZA200702038B (en) | Pharmaceutical composition drospirenone and ethynyle-stradiol | |
EP1765373A4 (de) | Ozonisierte pharmazeutische zusammensetzungen und verfahren | |
HK1102395A1 (en) | Indene derivatives and process for the preparation thereof | |
IL181819A (en) | Use of Benzo-compound compounds for the preparation of pharmaceuticals and the uses of these @ compounds | |
EP1726313A4 (de) | Arzneimittel zur prävention und behandlung von arteriosklerose | |
IL183702A0 (en) | Difluoronucleosides and process for preparation thereof | |
EP1756036A4 (de) | Indenderivate und verfahren zu deren herstellung | |
ZA200701496B (en) | Post-foaming dental mousse and methods utilizing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070306 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KOMI, JANNE Inventor name: BLOM, TARU Inventor name: LAMMINTAUSTA, RISTO |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/085 20060101AFI20100615BHEP Ipc: A61K 31/10 20060101ALI20100615BHEP Ipc: A61P 5/32 20060101ALI20100615BHEP Ipc: A61K 31/135 20060101ALI20100615BHEP Ipc: A61K 31/395 20060101ALI20100615BHEP Ipc: A61K 31/4164 20060101ALI20100615BHEP Ipc: A61P 5/26 20060101ALI20100615BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100628 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110126 |